CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 96 filers reported holding CYTOSORBENTS CORP in Q3 2021. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $372,127 | -56.4% | 197,940 | -16.8% | 0.52% | -45.5% |
| Q2 2023 | $854,205 | +6.5% | 237,940 | 0.0% | 0.96% | +3.0% |
| Q1 2023 | $801,858 | +108.7% | 237,940 | -4.0% | 0.94% | +99.8% |
| Q4 2022 | $384,307 | +11.7% | 247,940 | -2.0% | 0.47% | +25.1% |
| Q3 2022 | $344,000 | -14.2% | 253,000 | +38.3% | 0.37% | -7.7% |
| Q2 2022 | $401,000 | -32.0% | 183,000 | -1.1% | 0.40% | +12.8% |
| Q1 2022 | $590,000 | -23.9% | 185,000 | 0.0% | 0.36% | +3.8% |
| Q4 2021 | $775,000 | -48.4% | 185,000 | 0.0% | 0.35% | -36.6% |
| Q3 2021 | $1,502,000 | +7.5% | 185,000 | 0.0% | 0.55% | +18.4% |
| Q2 2021 | $1,397,000 | +28.8% | 185,000 | +48.0% | 0.46% | +9.8% |
| Q1 2021 | $1,085,000 | – | 125,000 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 450,000 | $846,000 | 0.90% |
| Skylands Capital, LLC | 2,944,670 | $5,535,980 | 0.84% |
| Sargent Investment Group, LLC | 1,257,048 | $2,363,250 | 0.57% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 197,940 | $372,127 | 0.52% |
| Avenir Corp | 2,717,397 | $5,108,706 | 0.48% |
| Granahan Investment Management | 1,552,393 | $2,918,499 | 0.10% |
| Seelaus Asset Management LLC | 20,450 | $38,446 | 0.04% |
| HighMark Wealth Management LLC | 10,000 | $18,800 | 0.02% |
| Key Client Fiduciary Advisors, LLC | 13,000 | $24,440 | 0.02% |
| Eudaimonia Partners, LLC | 23,500 | $44,180 | 0.01% |